Sector News

Raptor Pharma (RPTP) Appoints New SVP, Gen. Counsel

July 16, 2015
Life sciences
Raptor Pharma announced the appointment of Ashley Gould, J.D. as its Senior Vice President, General Counsel and Corporate Governance. In addition, Ted Daley, Chief Business Officer, will be leaving the company at the end of September to pursue other interests.
 
“I am delighted to welcome Ashley to Raptor’s executive team,” said Julie Anne Smith, President and CEO of Raptor Pharmaceutical. “She has highly relevant expertise in biopharma spanning regulatory, quality assurance, governmental, and legal in addition to other functions. As Raptor continues to grow, I am confident she will prove an excellent strategic addition and I look forward to her counsel. Separately, I would like to thank Ted for all of the contributions he has made to Raptor’s success over the years. His involvement across all functions has been invaluable as we’ve grown into a commercial, global organization. On behalf of the Board and other members of the executive team, we wish him well in his future endeavors.”
 
Most recently Ms. Gould served as Senior Vice President, Governmental Affairs and Chief Legal and Compliance Officer for Hyperion Therapeutics. Before that, she held a number of positions of increasing responsibility at 23andMe, culminating in her appointment as Vice President, Corporate Development and Chief Legal Officer. Previously she was Vice President, Legal Affairs at CoTherix, where she worked on the company’s acquisition by Actelion, and an associate at the law firms of O’Melveny & Myers and Wilson Sonsini Goodrich & Rosati. Ms. Gould received a B.S. in Political Economy of Natural Resources from University of California, Berkeley and a J.D. from the University of San Francisco School of Law.
 
Source: Raptor

Related News

April 17, 2021

Thermo Fisher to buy research contractor PPD in $17B deal

Life sciences

Thermo Fisher Scientific plans to buy PPD for $17.4 billion to bolster its clinical research service offerings to pharmaceutical and biotech companies.

April 17, 2021

Nestlé finds supplement cocktail slashes preterm birth in major preconception study

Life sciences

Nestlé Research has linked a specific blend of myo-inositol (a type of sugar), probiotics, riboflavin, zinc and vitamins D, B6 and B12 to the decreased incidence of preterm birth when consumed before and during pregnancy.

April 17, 2021

Eli Lilly, riding pharma’s rising digital wave, drafts Apple exec to replace Shah as CDO

Life sciences

Eli Lilly hired a new digital chief from Apple in another consumer switch for pharma and as the industry speeds up its shift to online strategies.

Send this to a friend